Evidence map›Paper›PMID 41216115›Full record

ArticleCureus2025

Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Due to Trimethoprim: A Case Report.

Hammad Buksh Ilahi, Maheen Bhangwar Baloch, Eirini Kasfiki

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hammad Buksh IlahiMedicine and Surgery, Ziauddin University, Karachi, PAK.
Maheen Bhangwar BalochMedicine and Surgery, Ziauddin University, Karachi, PAK.
Eirini KasfikiInternal Medicine, Hull University Teaching Hospitals NHS Trust, Hull, GBR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Drug reaction with eosinophilia and systemic symptoms (DRESS) is a rare, severe, and potentially life-threatening drug hypersensitivity reaction characterized by cutaneous eruption, hematologic abnormalities, and internal organ involvement. Early recognition and prompt withdrawal of the culprit drug are crucial to reduce morbidity and mortality. We report a case of a 17-year-old woman with a psychiatric history who presented with a progressive maculopapular rash, fever, cough, and lethargy after initiation of trimethoprim for acne. Examination revealed a diffuse rash and bilateral chest crepitations. Laboratory studies showed elevated inflammatory markers, eosinophilia, and deranged liver function tests. Imaging demonstrated bilateral pulmonary infiltrates. Initial improvement was noticed with oral steroids, but her symptoms recurred on withdrawal. After which, corticosteroids were introduced, but despite this, her respiratory function deteriorated, necessitating intensive care admission. Microbiological investigations were negative for infection. Based on clinical features and drug association, along with European Registry of Severe Cutaneous Adverse Reaction Criteria (RegiSCAR) scoring, a diagnosis of DRESS syndrome secondary to trimethoprim, further complicated by pneumonitis, was made. The patient was treated with systemic corticosteroids with gradual clinical and biochemical improvement over six weeks. This case highlights trimethoprim as a potential but under-recognized trigger for DRESS syndrome. Early identification, discontinuation of the offending drug, and careful use of corticosteroids are essential to prevent severe complications. Clinicians should maintain a high index of suspicion for DRESS in patients presenting with rash, fever, eosinophilia, and multiorgan involvement following recent drug exposure.

Indexed as

cutaneous adverse drug reactiondrug-induced hypersensitivitydrug-induced pneumonitisdrug reaction with eosinophilia and systemic symptoms (dress)pulmonary complicationstrimethoprim

Identifiers

PMID41216115
PMCPMC12596900

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.